172 related articles for article (PubMed ID: 21596150)
1. Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
Gallez-Hawkins GM; Franck AE; Li X; Thao L; Oki A; Gendzekhadze K; Dagis A; Palmer J; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1662-72. PubMed ID: 21596150
[TBL] [Abstract][Full Text] [Related]
2. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.
Zaia JA; Sun JY; Gallez-Hawkins GM; Thao L; Oki A; Lacey SF; Dagis A; Palmer J; Diamond DJ; Forman SJ; Senitzer D
Biol Blood Marrow Transplant; 2009 Mar; 15(3):315-25. PubMed ID: 19203722
[TBL] [Abstract][Full Text] [Related]
3. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
Wu X; Yao Y; Bao X; Zhou H; Tang X; Han Y; Ma X; Liu Y; Chen J; Zhou H; Jing S; Gu B; Xu Y; Sun A; He J; Wu D
Biol Blood Marrow Transplant; 2016 Feb; 22(2):220-225. PubMed ID: 26476204
[TBL] [Abstract][Full Text] [Related]
4. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.
Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotype.
Sobecks RM; Askar M; Thomas D; Rybicki L; Kalaycio M; Dean R; Avery R; Mossad S; Copelan E; Bolwell BJ
Exp Clin Transplant; 2011 Feb; 9(1):7-13. PubMed ID: 21605017
[TBL] [Abstract][Full Text] [Related]
6. Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
Nakamura R; Gendzekhadze K; Palmer J; Tsai NC; Mokhtari S; Forman SJ; Zaia JA; Senitzer D; Marcucci G; Stein A
Leuk Res; 2019 Dec; 87():106230. PubMed ID: 31644966
[TBL] [Abstract][Full Text] [Related]
7. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
[TBL] [Abstract][Full Text] [Related]
8. Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation.
Li Y; Wang T; Hu X; Zhang H; Bao X; Wu D; He J
Clin Exp Immunol; 2021 Sep; 205(3):417-428. PubMed ID: 34085290
[TBL] [Abstract][Full Text] [Related]
9. KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).
Gallez-Hawkins GM; Li X; Franck AE; Gendzekhadze K; Nakamura R; Forman SJ; Senitzer D; Zaia JA
Hum Immunol; 2012 Nov; 73(11):1109-15. PubMed ID: 22939905
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
[TBL] [Abstract][Full Text] [Related]
11. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.
Casto AM; Seo S; Levine DM; Storer BE; Dong X; Hansen JA; Boeckh M; Martin PJ
Blood; 2021 Oct; 138(17):1628-1636. PubMed ID: 34269803
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of KIR ligands missing and cytomegalovirus reactivation in improving outcomes of haematopoietic stem cell transplantation from HLA-matched sibling donor for treatment of myeloid malignancies.
Cardozo DM; Marangon AV; da Silva RF; Aranha FJP; Visentainer JEL; Bonon SHA; Costa SCB; Miranda ECM; de Souza CA; Guimarães F
Hum Immunol; 2016 Oct; 77(10):861-868. PubMed ID: 27394130
[TBL] [Abstract][Full Text] [Related]
14. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.
Farzamikia N; Hejazian SM; Haghi M; Hejazian SS; Zununi Vahed S; Ardalan M
Immunogenetics; 2022 Apr; 74(2):207-212. PubMed ID: 35091752
[TBL] [Abstract][Full Text] [Related]
16. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
[TBL] [Abstract][Full Text] [Related]
17. Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation.
Giebel S; Nowak I; Wojnar J; Markiewicz M; Dziaczkowska J; Wylezol I; Krawczyk-Kulis M; Bloch R; Kusnierczyk P; Holowiecki J
Transplant Proc; 2006; 38(1):287-91. PubMed ID: 16504727
[TBL] [Abstract][Full Text] [Related]
18. The impact of donor full-length KIR2DS4 in the development of acute and chronic GVHD after unrelated allogeneic HSCT.
An K; Li B; Luo C; Wang J; Luo C; Chen J
Pediatr Transplant; 2020 Sep; 24(6):e13728. PubMed ID: 32594584
[TBL] [Abstract][Full Text] [Related]
19. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska-Jakubowicz A; Gozdowska J; Ciszek M; Pazik J; Ostaszewska A; Kosieradzki M; Nowak J; Durlik M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696053
[TBL] [Abstract][Full Text] [Related]
20. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients.
Stern M; Elsässer H; Hönger G; Steiger J; Schaub S; Hess C
Am J Transplant; 2008 Jun; 8(6):1312-7. PubMed ID: 18444913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
